Member Info for Winit

Thanks Kevin, I can tell you I was bloooomin damn chuffed, by far my biggest ever win and in most peoples book quite a lot of money.
I like others am studying SNG all the time and get some great helpful info on this bb (thanks where its due). As such it was easy for me to pile the winnings back into shares (all in SNG now).

Kevinl1977,
I fully understand your comment re: footy betting but if it's a bit of fun and a very low outlay (relative to your own spare capital) then I think why not.
Just before Xmas I had a 9 team accumulator football bet, £10 stake paid me £24.5K.
£20K of that went straight into shares and made an extra £5K, it's all in SNG now along with my original investment.
Good luck BJW and all.

Brand, a insightful post.
Thanks for info.
What a great week this is turning out to be !!
GLA.

I especially like:
"I’d like to think that I put patients and people first. Honesty and truthfulness and sharing are the things my parents taught me. Ambition is great, money is great, cars are great, holidays are great, but putting people first and appreciating the importance of empathy when you’re making a decision, is what I’d like to be remembered for"

Got Xmas decorations down just in time today !!....good omen.
Thurs 13th Jan 2022.

I am of the view positive results will be forthcoming very soon. In the event they do anyone thinking of trading short term after initial sharp rise may want to consider how quickly this could move on again afterwards. Anyone any thoughts on this?

"& rapid launch pending positive data & authorisations"

My SNG investment position reflects your position exactly HPHQ.
Best wishes to you and your daughter, as you say health is what matters most and too much stressing over share prices is not really a good thing.
GLA......

Thanks Jenny an interesting bit of "off topic"
As was stated earlier by another poster, I have witnessed an absurd level of playground bickering etc today on another share bb ( I most certainly did not get involved in the nonsense), so this (as usual) is a pleasant change.

Irrespective of the debate on this link, as I said before I think SNG are in the 2022 list, please correct me if I am wrong?

Try again:
https://www.**********.co.uk/articles/traders-cafe-with-zak-mir-bulletin-board-heroes-2022-preview-ab8fe2b

I think SNG are in list:
https://www.**********.co.uk/articles/traders-cafe-with-zak-mir-bulletin-board-heroes-2022-preview-ab8fe2b

Albayo:
You can note in the attached link that the vaccine you refer to is still pending WHO EUA approval.

http://www.bccdc.ca/Health-Info-Site/Documents/COVID-19_vaccine/WHO-EUA-qualified-covid-vaccines.pdf

Brill Axe, thank you.

Hi Axe, If it's an open invite, I would also love to be able to meet many folks on here. Always up for a good "do"
Best wishes everyone.

Any thoughts anyone?

jwd222 post just got me thinking and so I decided to buy some more Syn shares before close.
GLA

SI - Thanks again for all the info you have supplied.

Hi SI, I am new to this BB and much appreciate the video link you posted. I have been 'dabbling' in graphene related share investments, waiting for that magical right moment!!
Tirupati has particularly interested me for a while. I like many others feel there is a massive future for the graphene industry.
Thanks.

Just watched "It's a Wonderful Life" classic old movie with a heartwarming message around money haha.
Best Wishes to all and your families.

I am new to this board but have been "in" on this for a little while. Watched Suzy on webinars many times and always impressed with her.
I have enjoyed watching in on this board and thanks to all.
Merry Christmas and of course a prosperous New Year to you all.

Just digging back, I found a few quotes included on Parexel site at the time of agreement with Syn back in Oct 2020. Some strong words in there ! Thought worth sharing.

“There is a distinct sense of urgency, paired with a clear need for safety, in the race to find a treatment for the most debilitating and deadly consequences of COVID-19,” said Graciela Racaro, Senior Vice President and Global Head of Operations, Parexel Biotech. “Working with Synairgen, we are able to share our global reach, deep therapeutic expertise and innovative approaches to support a pivotal study of their novel, inhaled therapy.”

“In the past, we’ve always run our own clinical trials, working with hospitals and research centers,” said Richard Marsden, Chief Executive Officer for Synairgen. “In the case of the SG018 trial, however, there is a clear need to find a global partner to ensure a smooth, fast, and successful trial. We look forward to working with Parexel Biotech as we progress this potential breakthrough therapy for COVID-19 patients.”